These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6932563)

  • 21. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia.
    Woo MH; Hak LJ; Storm MC; Sandlund JT; Ribeiro RC; Rivera GK; Rubnitz JE; Harrison PL; Wang B; Evans WE; Pui CH; Relling MV
    J Clin Oncol; 2000 Apr; 18(7):1525-32. PubMed ID: 10735901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of acute leukemia with the L-asparaginase. Preliminary results based on 84 cases].
    Bernard J; Jacquillat C; Boiron M; Weil M; Bussel A; Larrieu MJ; Delobel J; Goguel A; Levy D; Tanzer J
    Presse Med (1893); 1970 Jan; 78(4):161-6. PubMed ID: 5264814
    [No Abstract]   [Full Text] [Related]  

  • 23. Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review.
    Abbott LS; Zakova M; Shaikh F; Shewaramani N; Punnett A; Dupuis LL
    Paediatr Drugs; 2015 Aug; 17(4):315-21. PubMed ID: 25862348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term infusion of L-asparaginase--an alternative to intramuscular injection?].
    Rodriguez T; Baumgarten E; Fengler R; Soumpasis D; Henze G
    Klin Padiatr; 1995; 207(4):207-10. PubMed ID: 7564153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of hypersensitivity reactions to PEG-asparaginase in children after intravenous and intramuscular administration.
    August KJ; Miller WP; Dalton A; Shinnick S
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):e283-6. PubMed ID: 23619117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing precipitin in the serum of a patient treated with L-asparaginase.
    Khan A; Hill JM
    J Lab Clin Med; 1969 May; 73(5):846-52. PubMed ID: 4976214
    [No Abstract]   [Full Text] [Related]  

  • 27. [New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase].
    Sikorska-Fic B; Makowska K; Rokicka-Milewska R
    Wiad Lek; 1998; 51 Suppl 4():233-6. PubMed ID: 10731974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated use of L-asparaginase in multi-drug therapy of childhood leukemia.
    Trueworthy RC; Sutow WW; Pullen J; Komp D; Berry DH
    Med Pediatr Oncol; 1978; 4(2):91-7. PubMed ID: 275534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Formation of specific IgG antibodies in l-asparaginase treatment. Distribution of IgG subclasses].
    Körholz D; Urbanek R; Nürnberger W; Jobke A; Göbel U; Wahn V
    Monatsschr Kinderheilkd; 1987 Jun; 135(6):325-8. PubMed ID: 3475571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with L-asparaginase.
    Oettgen HF; Tallal L; Tan CC; Murphy ML; Clarkson BD; Golbey RD; Krakoff IH; Karnofsky DA; Burchenal HJ
    Recent Results Cancer Res; 1970; 33():219-35. PubMed ID: 5292718
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials.
    Burke MJ; Devidas M; Maloney K; Angiolillo A; Schore R; Dunsmore K; Larsen E; Mattano LA; Salzer W; Winter SS; Carroll W; Winick NJ; Loh ML; Raetz E; Hunger SP; Bleyer A
    Leuk Lymphoma; 2018 Jul; 59(7):1624-1633. PubMed ID: 29115886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 35. [Delayed hypersensitivity reaction caused by asparaginase].
    Couselo JM; Iglesias Diz JL
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():153-4. PubMed ID: 3214028
    [No Abstract]   [Full Text] [Related]  

  • 36. A desensitization protocol in children with L-asparaginase hypersensitivity.
    Akbayram S; Doğan M; Akgün C; Caksen H; Oner AF
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):e187-91. PubMed ID: 20505537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation.
    Kloos RQ; Pieters R; Escherich G; van der Sluis IM
    Pediatr Blood Cancer; 2016 Nov; 63(11):1928-34. PubMed ID: 27376478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies].
    Körholz D; Wahn U; Jürgens H; Wahn V
    Monatsschr Kinderheilkd; 1990 Jan; 138(1):23-5. PubMed ID: 2314401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.